KRTAP2-4
gene geneOn this page
Also known as KAP2.4
Summary
KRTAP2-4 (keratin associated protein 2-4, HGNC:18891) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 2-4 (Q9BYR9). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the high sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.
Source: NCBI Gene 85294 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_033184
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18891 |
| Approved symbol | KRTAP2-4 |
| Name | keratin associated protein 2-4 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP2.4 |
| Ensembl gene | ENSG00000213417 |
| Ensembl biotype | protein_coding |
| Entrez | 85294 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000394015
RefSeq mRNA: 1 — MANE Select: NM_033184
NM_033184
CCDS: CCDS32648
Canonical transcript exons
ENST00000394015 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001517235 | 41065116 | 41065879 |
Expression profiles
Bgee: expression breadth broad, 38 present calls, max score 41.40.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 41.40 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.73 | silver quality |
| right lung | UBERON:0002167 | 39.07 | gold quality |
| zone of skin | UBERON:0000014 | 38.97 | gold quality |
| skin of leg | UBERON:0001511 | 37.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.24 | gold quality |
| blood | UBERON:0000178 | 28.64 | gold quality |
| tonsil | UBERON:0002372 | 28.64 | gold quality |
| muscle of leg | UBERON:0001383 | 28.39 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| gastrocnemius | UBERON:0001388 | 27.95 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| cortex of kidney | UBERON:0001225 | 27.00 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| leukocyte | CL:0000738 | 26.03 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| monocyte | CL:0000576 | 25.88 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting KRTAP2-4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-6804-5P | 98.39 | 65.77 | 1084 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-4483 | 98.09 | 64.12 | 1642 |
| HSA-MIR-12116 | 97.94 | 68.91 | 595 |
| HSA-MIR-299-3P | 97.73 | 66.67 | 773 |
| HSA-MIR-8055 | 97.62 | 66.09 | 1023 |
| HSA-MIR-3622A-3P | 97.06 | 66.43 | 1000 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap5-2 | ENSMUSG00000054759 |
| mus_musculus | Krtap5-20 | ENSMUSG00000056885 |
| mus_musculus | Krtap5-26 | ENSMUSG00000109859 |
| mus_musculus | Krtap5-24 | ENSMUSG00000110324 |
| rattus_norvegicus | Krtap5-8 | ENSRNOG00000020131 |
| rattus_norvegicus | AABR07006049.1 | ENSRNOG00000046649 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 2-4 — Q9BYR9 (reviewed: Q9BYR9)
Alternative names: High sulfur keratin-associated protein 2.4, Keratin-associated protein 2.4
All UniProt accessions (1): Q9BYR9
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Expressed specifically in the middle/upper portions of the hair cortex, in the region termed the keratogenous zone.
Similarity. Belongs to the KRTAP type 2 family.
RefSeq proteins (1): NP_149440* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
| IPR052154 | KRTAP_type_2-like | Family |
Pfam: PF01500
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYR9-F1 | 33.60 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 74 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, LHX9_TARGET_GENES, MAFG_TARGET_GENES, PRMT5_TARGET_GENES, SUPT16H_TARGET_GENES, ZNF175_TARGET_GENES, ZNF197_TARGET_GENES, ZNF589_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
271 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SDC3 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZDHHC1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VASN | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB5 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP2-4 | HAPLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNP2 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLC | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDL1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAHD1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXB9 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1E | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| P2RY6 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2C | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF764 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| C11orf87 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP9-3 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IGSF8 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| JOSD1 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1B | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXCL16 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF524 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF672 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA3 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAMTSL3 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-4 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-12 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (199): KRTAP2-4 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-4 (Two-hybrid), PTPMT1 (Two-hybrid), TMEM190 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-3 (Two-hybrid), KRTAP2-4 (Two-hybrid), KRTAP2-3 (Two-hybrid), KRTAP2-4 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: P02441, P02442, P02443, P0C7H8, Q9BYR9, Q9BYT5, Q9BYU5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 21 | 22.5× | 1e-21 |
| Formation of the cornified envelope | 11 | 18.6× | 6e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 11 | 34.3× | 4e-12 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
197 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41065804:G:C | donor_gain | 0.8600 |
| 17:41065796:C:A | donor_gain | 0.7800 |
| 17:41065797:C:A | donor_gain | 0.7600 |
| 17:41065634:T:A | donor_gain | 0.7400 |
| 17:41065157:T:TC | acceptor_gain | 0.6200 |
| 17:41065795:T:TA | donor_gain | 0.6000 |
| 17:41065584:C:CT | donor_gain | 0.5900 |
| 17:41065153:CACAT:C | acceptor_gain | 0.5800 |
| 17:41065339:C:CT | acceptor_gain | 0.5800 |
| 17:41065808:A:AC | donor_gain | 0.5700 |
| 17:41065119:C:CT | acceptor_gain | 0.5600 |
| 17:41065635:C:A | donor_gain | 0.5600 |
| 17:41065725:A:T | donor_gain | 0.5600 |
| 17:41065155:CAT:C | acceptor_gain | 0.5500 |
| 17:41065394:A:C | donor_gain | 0.5500 |
| 17:41065659:A:T | donor_gain | 0.5500 |
| 17:41065660:C:T | donor_gain | 0.5400 |
| 17:41065664:G:T | donor_gain | 0.5400 |
| 17:41065323:TAC:T | donor_gain | 0.5300 |
| 17:41065324:ACA:A | donor_gain | 0.5300 |
| 17:41065325:CAC:C | donor_gain | 0.5300 |
| 17:41065366:T:C | acceptor_gain | 0.5300 |
| 17:41065663:C:CT | donor_gain | 0.5200 |
| 17:41065325:CA:C | donor_gain | 0.5100 |
| 17:41065422:AGG:A | donor_gain | 0.5100 |
| 17:41065630:G:GA | donor_gain | 0.5100 |
| 17:41065157:T:C | acceptor_gain | 0.5000 |
| 17:41065250:T:C | donor_gain | 0.4900 |
| 17:41065462:G:C | donor_gain | 0.4800 |
| 17:41065696:G:A | donor_gain | 0.4800 |
AlphaMissense
812 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41065564:C:A | W94C | 0.938 |
| 17:41065564:C:G | W94C | 0.938 |
| 17:41065581:A:G | C89R | 0.937 |
| 17:41065579:G:C | C89W | 0.917 |
| 17:41065611:A:G | C79R | 0.897 |
| 17:41065616:A:G | I77T | 0.892 |
| 17:41065580:C:T | C89Y | 0.889 |
| 17:41065580:C:G | C89S | 0.873 |
| 17:41065581:A:T | C89S | 0.873 |
| 17:41065616:A:T | I77N | 0.873 |
| 17:41065609:G:C | C79W | 0.872 |
| 17:41065616:A:C | I77S | 0.871 |
| 17:41065566:A:G | W94R | 0.870 |
| 17:41065566:A:T | W94R | 0.870 |
| 17:41065596:A:G | C84R | 0.852 |
| 17:41065606:G:C | C80W | 0.841 |
| 17:41065632:C:G | G72R | 0.839 |
| 17:41065569:A:G | C93R | 0.838 |
| 17:41065567:G:C | C93W | 0.835 |
| 17:41065570:G:C | C92W | 0.834 |
| 17:41065626:A:G | C74R | 0.826 |
| 17:41065577:C:A | R90M | 0.824 |
| 17:41065574:G:T | P91H | 0.821 |
| 17:41065610:C:T | C79Y | 0.821 |
| 17:41065594:G:C | C84W | 0.818 |
| 17:41065733:G:A | T38I | 0.811 |
| 17:41065624:G:C | C74W | 0.810 |
| 17:41065576:C:A | R90S | 0.809 |
| 17:41065576:C:G | R90S | 0.809 |
| 17:41065629:A:G | C73R | 0.809 |
dbSNP variants (sampled 300 via entrez): RS1000739351 (17:41066406 G>A), RS1000803836 (17:41065297 G>A,C,T), RS1002643276 (17:41066851 A>C), RS1004194978 (17:41065209 A>C), RS1004535847 (17:41066658 C>T), RS1004585476 (17:41066811 T>A,C), RS1007435089 (17:41066077 C>A,T), RS1008340730 (17:41064864 G>A), RS1008453605 (17:41064641 A>T), RS1008665871 (17:41066244 T>C), RS1009437357 (17:41066870 A>C), RS1011831935 (17:41065233 G>A), RS1011904265 (17:41065496 G>A,T), RS1012413117 (17:41066893 A>G), RS1013509052 (17:41066365 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Formaldehyde | decreases expression, increases expression | 2 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Copper Sulfate | increases expression | 1 |
| Genistein | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.